SCHEMBL8241328

SCHEMBL8241328

Oc1c(Cl)cc(Br)cc1/C=N/Nc1nc(Nc2ccccc2)nc(Nc2ccccc2)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDX3X O00571 6/20 0.59
▸ KMT2A Q03164 10/20 0.55
▸ MAPT P10636 9/20 0.55
▸ MEN1 O00255 9/20 0.55
▸ HTT P42858 6/20 0.55
▸ RAB9A P51151 5/20 0.55
▸ KDM4E B2RXH2 5/20 0.55
▸ NPC1 O15118 3/20 0.51
▸ MITF O75030 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ NPSR1 Q6W5P4 3/20 0.47
▸ TDP1 Q9NUW8 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ GAA P10253 2/20 0.45
▸ POLB P06746 2/20 0.45
▸ GFER P55789 1/20 0.45
▸ GPR39 O43194 1/20 0.44
▸ CA12 O43570 2/20 0.44
▸ CA1 P00915 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14527789 0.88 DDX3X (0.61) DDX3XKMT2AMAPTMEN1HTT
SCHEMBL8238853 0.88 DDX3X (0.61) DDX3XKMT2AMAPTMEN1HTT
SCHEMBL8239302 0.78 DDX3X (0.50) DDX3XKMT2AMAPTMEN1HTT
SCHEMBL19862522 0.77 RAB9A (0.58) KMT2AMAPTMEN1HTTRAB9A
SCHEMBL8238843 0.77 DDX3X (0.68) DDX3XKMT2AMAPTMEN1HTT
SCHEMBL13548867 0.76 RAB9A (0.82) KMT2AMAPTMEN1HTTRAB9A
SCHEMBL8231988 0.76 DDX3X (0.61) DDX3XKMT2AMAPTMEN1HTT
SCHEMBL13548884 0.74 KMT2A (0.60) KMT2AMAPTMEN1HTTRAB9A
SCHEMBL11913667 0.74 DDX3X (1.00) DDX3XKMT2AMAPTMEN1HTT
SCHEMBL13548897 0.73 RAB9A (0.52) KMT2AMAPTMEN1HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007051333-A1 TRIAZINE BETA-SECRETASE INHIBITORS ONCALIS AG (CH) 2007-05-10 — — WO disclosed
Send feedback